199 related articles for article (PubMed ID: 31843189)
1. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.
Samaratunga H; Delahunt B; Egevad L; Srigley JR; Billis A; Bostwick DG; Camparo P; Cheng L; Clouston D; Denham J; Furusato B; Hartmann A; Jufe L; Kench J; Kenwright DN; Kristiansen G; Leite KRM; MacLennan GT; Merrimen J; Moch H; Oxley J; Pan CC; Paner G; Ro J; Sesterhenn IAM; Shanks J; Thunders M; Tsuzuki T; Wheeler T; Yaxley JW; Varma M
Pathology; 2020 Feb; 52(2):192-196. PubMed ID: 31843189
[TBL] [Abstract][Full Text] [Related]
2. Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies.
Chen-Maxwell D; Prendeville S
Histopathology; 2020 Sep; 77(3):503-507. PubMed ID: 32358793
[TBL] [Abstract][Full Text] [Related]
3. Intraductal carcinoma of the prostate: a critical re-appraisal.
Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
Virchows Arch; 2019 May; 474(5):525-534. PubMed ID: 30825003
[TBL] [Abstract][Full Text] [Related]
4. Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist.
Varma M
Adv Anat Pathol; 2021 Jul; 28(4):276-287. PubMed ID: 33990497
[TBL] [Abstract][Full Text] [Related]
5. Head to head: should the intraductal component of invasive prostate cancer be graded?
Varma M; Epstein JI
Histopathology; 2021 Jan; 78(2):231-239. PubMed ID: 32692448
[TBL] [Abstract][Full Text] [Related]
6. Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic Parameter.
Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L
Am J Surg Pathol; 2021 Nov; 45(11):1527-1533. PubMed ID: 34265803
[TBL] [Abstract][Full Text] [Related]
7. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
8. Intraductal carcinoma of the prostate in the ejaculatory duct.
Sanchez-Salazar AJ; Basler JW; Nicolas MM
Int J Surg Pathol; 2010 Aug; 18(4):298-9. PubMed ID: 20444733
[TBL] [Abstract][Full Text] [Related]
9. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
Russell DH; Epstein JI
Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708
[TBL] [Abstract][Full Text] [Related]
10. Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.
Sorvina A; Martini C; Prabhakaran S; Logan JM; S-Y Ung B; Moore C; Johnson IRD; Lazniewska J; Tewari P; Malone V; Brooks RD; Hickey SM; Caruso MC; Klebe S; Karageorgos L; O'Leary JJ; Delahunt B; Samaratunga H; Brooks DA
Pathology; 2023 Oct; 55(6):792-799. PubMed ID: 37422404
[TBL] [Abstract][Full Text] [Related]
11. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications.
Henry PC; Evans AJ
J Clin Pathol; 2009 Jul; 62(7):579-83. PubMed ID: 19246509
[TBL] [Abstract][Full Text] [Related]
12. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
[TBL] [Abstract][Full Text] [Related]
13. Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study.
Acosta AM; Vormittag E; Al Rasheed MRH; Sharif A; Mon KS; Kajdacsy-Balla A; Mohapatra G
Pathol Res Pract; 2018 Oct; 214(10):1681-1685. PubMed ID: 30195638
[TBL] [Abstract][Full Text] [Related]
14. [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].
Kristiansen G; Egevad L; Amin M; Delahunt B; Srigley JR; Humphrey PA; Epstein JI;
Pathologe; 2016 Feb; 37(1):17-26. PubMed ID: 26809207
[TBL] [Abstract][Full Text] [Related]
15. Grading Intraductal Carcinoma of the Prostate; ISUP versus GUPS Recommendations.
Shahid A; Mushtaq S; Maqbool H; Hassan U; Hussain M; Syed M
J Coll Physicians Surg Pak; 2023 Apr; 33(4):396-399. PubMed ID: 37190710
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
[TBL] [Abstract][Full Text] [Related]
17. Intraductal Carcinoma of the Prostate Gland: Recent Advances.
Divatia MK; Ro JY
Yonsei Med J; 2016 Sep; 57(5):1054-62. PubMed ID: 27401634
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.
Trudel D; Downes MR; Sykes J; Kron KJ; Trachtenberg J; van der Kwast TH
Eur J Cancer; 2014 Jun; 50(9):1610-6. PubMed ID: 24703897
[TBL] [Abstract][Full Text] [Related]
19. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
20. Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series.
Siadat F; Sykes J; Zlotta AR; Aldaoud N; Egawa S; Pushkar D; Kuk C; Bristow RG; Montironi R; van der Kwast T
Prostate; 2015 Sep; 75(12):1277-84. PubMed ID: 25963383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
